GGrantIndex
← Leaderboards

Marc J Lallemant

Harvard University (Sch Of Public Hlth)

$19,725,823
Attributed
$19,725,823
Total exposure
7
Grants
4
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $4.3M · FY200613
$5M$3.8M$2.5M$1.3M$0
'06
'07
'08
'09
'10
'11
'12
'13

Funding mix

By agency

NIH$19,725,823 · 7

By mechanism

R01$14,633,486 · 5
U01$5,011,697 · 1
R03$80,640 · 1

Top collaborators

No co-investigators on record.

Most similar at Harvard University (Sch Of Public Hlth)

Same institution · by research overlap

Others in their field

Top investigators on “Hiv Infections

Research focus

Hiv InfectionsBaseThailandAids PreventionChildClinical ResearchHospitalsPublic Health Medicine (Field)ZidovudineGuidelinesPreventAnti-Retroviral AgentsNevirapineClinical Research SitePerinatalBirthDrug KineticsAntiretroviral TherapyMothersFranceImmunocompromised HostImmuneInfantCd4 Lymphocyte Count

Grant awards (25)

Lopinavir/ritonavir + zidovudine to prevent perinatal HIV in Thailand$253,264
R01 · FY2013 · HD · contact PI
Standard zidovudine plus infant nevirapine to prevent perinatal HIV in Thailand$633,597
R01 · FY2010 · HD · contact PI
Lopinavir/ritonavir + zidovudine to prevent perinatal HIV in Thailand$348,934
R01 · FY2010 · HD · contact PI
Program for HIV Prevention and Treatment-Clinical Trial Unit, Thailand$136,242
U01 · FY2010 · AI · contact PI
Program for HIV Prevention and Treatment-Clinical Trial Unit, Thailand$1,035,825
U01 · FY2009 · AI · contact PI
Standard zidovudine plus infant nevirapine to prevent perinatal HIV in Thailand$670,827
R01 · FY2009 · HD · contact PI
Lopinavir/ritonavir + zidovudine to prevent perinatal HIV in Thailand$479,230
R01 · FY2009 · HD · contact PI
Program for HIV Prevention and Treatment-Clinical Trial Unit, Thailand$2,142,292
U01 · FY2008 · AI · contact PI
Monitoring HAART in HIV-infected parents in Thailand$944,363
R01 · FY2008 · HD · contact PI
Standard zidovudine plus infant nevirapine to prevent perinatal HIV in Thailand$733,625
R01 · FY2008 · HD · contact PI
Lopinavir/ritonavir + zidovudine to prevent perinatal HIV in Thailand$475,356
R01 · FY2008 · HD · contact PI
Program for HIV Prevention and Treatment-Clinical Trial Unit, Thailand$1,697,338
U01 · FY2007 · AI · contact PI
Monitoring HAART in HIV-infected parents in Thailand$1,088,196
R01 · FY2007 · HD · contact PI
Standard zidovudine plus infant nevirapine to prevent perinatal HIV in Thailand$766,697
R01 · FY2007 · HD · contact PI
Lopinavir/ritonavir + zidovudine to prevent perinatal HIV in Thailand$428,547
R01 · FY2007 · HD · contact PI
Monitoring HAART in HIV-infected parents in Thailand$1,086,922
R01 · FY2006 · HD · contact PI
Standard zidovudine plus infant nevirapine to prevent perinatal HIV in Thailand$702,356
R01 · FY2006 · HD · contact PI
Monitoring HAART in HIV-infected parents in Thailand$1,110,176
R01 · FY2004 · HD
Monitoring HAART in HIV-infected parents in Thailand$809,398
R01 · FY2003 · HD
NEVIRAPINE+ZIDOVUDINE--PREVENT PERINATAL HIV IN THAILAND$1,044,972
R01 · FY2002 · HD
NEVIRAPINE+ZIDOVUDINE--PREVENT PERINATAL HIV IN THAILAND$1,554,692
R01 · FY2001 · HD
HBV, HCV, CMV &HHV-8 IN HIV POSITIVE WOMEN IN THAILAND$40,320
R03 · FY2001 · TW
NEVIRAPINE+ZIDOVUDINE--PREVENT PERINATAL HIV IN THAILAND$1,134,396
R01 · FY2000 · HD
SHORT ZDV COURSE TO PREVENT PERINATAL HIV IN THAILAND$367,938
R01 · FY2000 · HD
HBV, HCV, CMV &HHV-8 IN HIV POSITIVE WOMEN IN THAILAND$40,320
R03 · FY2000 · TW